Radioactive metal-labeled anti-cadherin antibody
US8815211B2 · kind B2 · utility
1Cited by
0References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 9, 2011 |
| Grant date | Aug 26, 2014 |
| Priority date | — |
| Expiry date | Feb 9, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An object of the present invention is to provide a radioactive metal anti-cadherin antibody which is highly accumulated specifically in cancer tissue. Another object is to provide a cancer therapeutic agent having high anti-cancer effect and safety and a cancer diagnostic agent. The radioactive metal-labeled anti-cadherin antibody is obtained by binding a radioactive metallic element to an anti-cadherin antibody via a metal-chelating reagent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.